BZAI vs SIFY vs AEHR vs HCTI

For growth investors, Sify Technologies Limited (SIFY) is the stronger pick with 11.

9% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Analysts rate Blaize Holdings, Inc. (BZAI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +38.

9%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: AEHR returned +70. 3% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Sify Technologies Limited (SIFY) is the lower-risk stock at 1.

33β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 260% more volatile than SIFY relative to the S&P 500. On balance sheet safety, Blaize Holdings, Inc. (BZAI) carries a lower debt/equity ratio of 6% versus 196% for Sify Technologies Limited — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sify Technologies Limited (SIFY) is pulling ahead at 11.

9% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to -877. 8% for Sify Technologies Limited. Over a 3-year CAGR, SIFY leads at 13. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Sify Technologies Limited (SIFY) is the more profitable company, earning -2.

0% net margin versus -39. 4% for Blaize Holdings, Inc. — meaning it keeps -2. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SIFY leads at 5. 7% versus -30. 7% for BZAI. At the gross margin level — before operating expenses — BZAI leads at 62. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Sify Technologies Limited (SIFY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+141.

0% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 07 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SIFY: +141. 0%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BZAI (Technology) and SIFY (Communication Services) and AEHR (Technology) and HCTI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.